HER4通过PTEN-PI3K/AKT通路促进骨肉瘤进展并预测预后不良。

IF 3.3 3区医学 Q2 ONCOLOGY

Journal of Cancer Pub Date : 2025-01-16 eCollection Date: 2025-01-01 DOI:10.7150/jca.110321

Kun Ma, Chuan Zhang

引用次数: 0

摘要

[本文撤回文章DOI: 10.7150/jca.62787.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway: Retraction.

[This retracts the article DOI: 10.7150/jca.62787.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cancer ONCOLOGY-

CiteScore

8.10

自引率

2.60%

发文量

333

审稿时长

12 weeks

期刊介绍： Journal of Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. Journal of Cancer aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process.